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Abstract
Introduction: Inherited retinal dystrophies are major cause of severe progressive vision loss in children. Early
recognition and diagnosis are essential for timely visual rehabilitation during the appropriate stages of the visual
development, as well as for genetic diagnosis and possible gene therapy. The aim of this study is to characterize a
pattern of the initial visual symptoms, which could help the pediatricians and the primary care providers to suspect
an inherited retinal disorder in its early stage.
Methods: We analyzed the initial clinical symptoms, based on parental report during the first visit to specialist, in
50 children diagnosed with retinal dystrophy confirmed by full-field electroretinography. The analysis included the
age of symptoms onset and the type of visual symptoms, both in the total population and in the following
diagnostic subgroups: rod-cone dystrophy (n.17), cone-rod dystrophy (n.12), achromatopsia (n.13), congenital
stationary night blindness (n.6) and Leber’s congenital amaurosis (n.2).
Results: The majority of children (80%) had the onset of clinical symptoms before one year of age. The most
frequent visual complaints reported by parents were nystagmus (76%), visual loss (28%) and photophobia (8%).
Nystagmus was the first symptom reported by parents if the disease onset was before the age of six months, while
the onset after the six months of age was more likely associated with the complain of vision loss.
Conclusions: Low vision and nystagmus observed by parents, particularly in the first year of life, may represent a
red flag, prompting an appropriate ophthalmological workup for inherited retinal dystrophy.
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Introduction
Inherited Retinal Dystrophies (IRDs) are a major cause of
severe progressive vision loss in children. They include a
large group of clinically and genetically heterogeneous
disorders that affect approximately 1 in 3000 patients [1],
with more than 271 causative genes identified to date
(RetNet: https://sph.uth.edu/retnet/ 9 March 2019).
At early stages, the fundus oculi examination may be
normal or not specific. Furthermore; the diagnostic tests
that can reveal features of IRDs in adults [2] are often
either difficult to perform or not reliable in very young
children. Research shows that the electroretinogram
(ERG) can be used as an objective assessment method,
independent of the child’s cooperation. Its diagnostic role
has been now well established in pediatric IRDs [3–6].
The ERG evaluates the retina-wide function of rods and
cones, and it can confirm a clinical suspicion for diffuse
photoreceptor disease, the most frequent IRD types in
childhood [7]. However, in the absence of clear clinical
clues, clinicians are often reluctant to prescribe ERG test-
ing in young children, potentially prolonging the time to
diagnosis.
In adult IRD patients, the retrospective evaluation of the
initial symptoms pattern was proven useful in providing
additional clues for early disease recognition and also for in-
clusion in clinical trials [7]. Similar studies are not available
in the pediatric population. The initial manifestation of IRD
depends on the specific type of photoreceptor dysfunction.
Color blindness, low vision, increased sensitivity to bright
lights and nystagmus represent cones dysfunction [8, 9];
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: agnese.suppiej@unife.it
1Department of Medical Sciences - Pediatric Section, University of Ferrara,
Ferrara, Italy
2Robert Hollman Foundation, Padua, Italy
Full list of author information is available at the end of the article
Suppiej et al. Italian Journal of Pediatrics          (2019) 45:168 
https://doi.org/10.1186/s13052-019-0760-5
while night vision problems and reduced peripheral visual
fields are associate with rods dysfunction [10]. In the pro-
gressive forms of IRDs, there can be an initial dysfunction of
the cones, followed by a progression to rods dysfunction, or
alternatively, the IRD can affect rods first and then progress
to cones [11–13].
We believe that the identification of clinical clues that
may suggest early IRDs in children may improve the
time to diagnosis. Early diagnosis is important for the
access to visual rehabilitation during the appropriate
developmental window, for further investigations, but
increasingly also for a genetic diagnosis, and parental
genetic counselling. Indeed, timely recognition and opti-
mal multidisciplinary management of these disorders
can have very important implications for improving chil-
dren’s quality of life [4]. Furthermore, gene replacement
therapies are on the way for some IRDs and in those
cases the early diagnosis will be essential [14–16].
The aim of this study was to analyze the initial signs
and symptoms of IRD as reported by the parents at the
initial ophthalmological visit, in a cohort of 50 children
diagnosed with IRD. The ultimate goal was to identify
clinical clues that will help the pediatrician to suspect a
retinal dystrophy.
Subjects and methods
The study group included 50 patients (30 males), diag-
nosed with isolated retinal dystrophy, and confirmed by
the ERG. Children were all born at term, except one born
at 36 weeks gestation. Mean gestational age was 39 weeks
(range 36–42). Mean age 4 years and eight months (range
5months − 14 years), The patients were recruited from
the database of our institutions. The patients’ data were
prospectively collected over a period of 7 years, following
an initial clinical evaluation by a paediatric ophthalmolo-
gist and electroretinography. Children were eligible for the
study if they had adequate clinical and diagnostic data.
The minimum dataset for inclusion in the present study
was a detailed medical history collected at the first special-
ist’s visit, including a structured interview focused on the
first clinical signs observed by the parents. The interview
included the age of symptoms onset and the following
items: suspected vision loss, such as the inability to visu-
ally fixate or follow an object or light; visual field abnor-
mality/bumping into objects; inability to recognize colors;
worsening of the night vision; increased sensitivity to
bright light (i.e. photophobia); and nystagmus. Nystagmus
was defined as involuntary, rhythmic, conjugate oscillatory
movement of the eyes [17].
In order to confirm the diagnosis of retinal dystrophy
we also collected the full report of the initial ophthalmo-
logical examination including at the minimum fundus
oculi, visual acuity tests appropriate for age and complete
electrophysiology. Systemic evaluation and additional non-
ophthalmologic assessments (audiometric and vestibular
tests, metabolic work-up, kidney function, ultrasounds,
neurological examination and brain magnetic resonance
imaging) were also searched, to rule out systemic disorders
presenting with retinal dystrophy. In order to categorize the
degenerative forms, we compared the distribution of signs
and symptoms at the first and the last ophthalmological
visits, as well as the ERG in at least two time points.
Patients who had inadequate data and those with diagnosis
of syndromic or metabolic retinal dystrophies were not
recruited. The diagnosis of isolated retinal dystrophy was
confirmed by retrospective analysis of medical records and
electroretinography. The ERG, objectively diagnosed retinal
dysfunction even in patients without a visible fundus oculi
abnormality. The ERG had specific patterns of retinal dys-
function consistent with the subtype classification of inher-
ited retinal dystrophies.
Patients were categorized into five IRD diagnostic
subtypes, according to ophthalmological and ERG criteria
[3, 18]: 1) rod-cone dystrophy (RCD) 17 patients (34%); in
all the scotopic ERG was severely involved while the pho-
topic ERG had abnormalities of variable severity, deteriorat-
ing at follow up.2) cone-rod dystrophy (CRD) 12 (24%); in
all the photopic ERG was abnormal while the scotopic ERG
was abnormal in five cases, severity of photopic ERG
involvement exceeded that of scotopic ERG, at follow up
both photopic and scotopic ERGs deteriorated in all cases.
3) achromatopsia (ACHR) 13 (26%); the photopic ERG was
severely depressed in all, 3 out of 13 patients had also a
mild reduction in amplitude of the scotopic ERG, these
findings were stable at follow up. 4) congenital stationary
night blindness (CSNB) 6 (12%), all had normal photopic
ERG and reduced amplitude of the scotopic ERG. 5) Leber’s
congenital amaurosis (LCA) 2 (4%), both patients had
severely abnormal ERG early in life.
Analysis included identification of the age of symptoms
onset and of the earliest visual signs/symptoms reported
by parents, both in the total population and in the five
IRD diagnostic subtypes.
Institutional Boards approved the retrospective review
of clinical and electrophysiological data.
Results
In our cohort of 50 children, the symptoms most fre-
quently reported by parents were nystagmus (76%), vi-
sion loss (28%) and photophobia (8%). Interestingly, only
a minority of parents reported bumping into objects or
suspected visual field loss (6%), difficulties with night
vision (4%) or problems with color vision (6%). The fre-
quencies of the three most frequent initial symptoms
differed among the five IRD subtypes (Table 1).
The mean age at the symptom onset was 12months
(range 2 months-5 years). The majority of patients (80%)
presented before 12 months. Male sex was prevalent in
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both the group with symptom onset before 12 months
and that with symptoms onset after 12 months (57% vs
70% respectively). Nystagmus was the most frequently
reported first symptom in children with the onset of
symptoms before 6 months of age, while the most fre-
quent symptom presenting after the 6 months of age was
visual loss (Fig. 1)
Discussion
The present study shows that the parents were able to
reliably recognize some of the earliest signs of IRD. We
identified nystagmus and visual loss as the most constant
clinical features reported by parents. The initial clinical
symptoms of IRD were apparent before the 12months
of age in the majority of patients of our cohort. Compar-
ing the symptoms by the age of onset, nystagmus was
the most frequently reported symptom before the age of
six months. By contrast, the onset of abnormal visual
behavior suggesting a visual loss, was more frequently
reported after 6 months of age.
While nystagmus, particularly the infantile form, can
be idiopathic; it can also be a sign of sensory loss due to
anterior visual pathways dysfunction, or it can be part of
neurological diseases involving the oculomotor system
[17, 19]. Clinically, sensory nystagmus worsens by fixing
on objects, while neurological nystagmus worsens with
eye movements. To distinguish infantile idiopathic nystag-
mus from sensory defect nystagmus can be challenging.
Indeed, about half of the children with infantile nystagmus
evaluated by expert pediatric ophthalmologists were sub-
sequently diagnosed with IRDs after electrophysiological
evaluation [20]. The etiology of the nystagmus can be con-
firmed by a combination of electrophysiology, laboratory
tests, neurological work up, and imaging [17].
Abnormal visual behavior can represent a significant
diagnostic challenge in young children. While this may
be a sign of neurological or ophthalmological disorders,
in can also represent a delayed visual maturation [21].
Confirming the diagnosis may be particularly difficult in
young children, since they are often unable to report
sensory loss, or to cooperate with clinical and instru-
mental testing. Especially in infants, the clinical suspicion
relies mostly on parental observation.
When ophthalmic inspection is uninformative, and the
diagnostic workup excluded neurological disorders of
the visual pathways and global developmental disability,
the diagnosis of IRD should be the next to consider. It is
noteworthy that the ERG was successfully performed in
all children of the present study and, in the appropriate
clinical setting, had confirmed the diagnosis in all
recruited patients. Electrophysiological techniques are
commonly considered difficult to perform in young chil-
dren and their interpretation requires specific knowledge
on normal waveforms at different ages. The ERG reflects
the functional activity of retinal photoreceptors, allowing
distinction between the cone and rod systems involve-
ment. Different ERG patterns corresponding to selective
or prevalent cones or rods dysfunction and their stable
or progressive trend during follow up were fundamental
for classification of IRD subtypes. This was particularly
important for diagnosis when the fundus oculi appear-
ance was normal or non-specific.
Parents of very young children frequently under-report
some clinical symptoms of IRD, such as photophobia,
color vision, night blindness and peripheral visual field
loss. As an example, in IRD forms with cone system
involvement, parents appreciated sensitivity to bright
light less often than nystagmus and vision loss, even in
Table 1 Percentage of symptoms and signs reported by children’s parents in the total population and in the five retinal dystrophy
subtypes
Nystagmus Photophobia Low vision
Total patients (50 patients) 76% 8% 28%
Rod-cone Distrophy (17 patients) 53% 0% 41%
Cone-rod Distrophy (12 patients) 92% 17% 42%
Achromatopsia (13 patients) 100% 8% 0%
CSNB (6 patients) 67% 0% 19%
Leber’s Amaurosis (2 patients) 50% 50% 100%
LCA = Leber’s congenital amaurosis; ACHR = achromatopsia; CSNB = congenital stationary night blindness; CRD = cone-rod dystrophy; RCD = rod-cone dystrophy
Fig. 1 Number of patients with nystagmus and visual loss as
symptoms at clinical onset of retinal dystrophy by age groups
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achromatopsia where photophobia is an early and dis-
tinctive feature. Currently there are no pediatric reports
describing pathognomonic clinical features that may
constitute red flags to alert clinicians to suspect the
diagnosis of IRD. In adults, recognizing the patterns of
initial symptoms allowed the differentiation between the
cone dystrophies, with early severe visual loss, from
earlier rods dysfunction, such as retinitis pigmentosa
with the initial symptom of night blindness [7].
Our study shows that in pediatric population, the early
symptoms of IRD reported by parents have less defined pat-
terns, as compared to the adult patients with IRD [7–13].
We hypothesize that there are two main reasons for this.
The first reason is a parental under-reporting of symptoms
that are difficult to recognize in very young children. The
second reason is the more aggressive and more diffuse
nature of retinal pathology in the early onset IRDs, leading
to the involvement of both, rod and cone systems early in
the course of disease.
What this study adds is the delineation of the early
clinical features in children with IRD, observable by the
parents, which could in turn help the pediatricians and
other primary care providers to suspect the disease.
Based on the results of our study we suggest that com-
prehensive evaluation of a child seen for a complaint of
vision loss or nystagmus, should include detailed ques-
tions looking for specific signs and symptoms of rods and
cones dysfunction, both often overlooked and underre-
ported. Presence of any of the symptoms should alert the
pediatrician to consider IRDs in the differential diagnosis
of vision loss and nystagmus.
A limitation of the present study was a relatively small
number of recruited subjects, precluding more detailed
analysis of clinical characteristics and age at onset by
retinal subgroups, as well as good statistical analysis.
Even if the focus of our study was to describe the early
clinical clues that would increase the pediatrician’s sus-
picion for retinal disorders, and we used electroretinog-
raphy to confirm the diagnosis, the lack of genetic data
is a limitation of the present study. Nowadays significant
achievements have been made in the elucidation of the
genetic causes of many IRDs [22] and to perform genetic
diagnosis should be be the final step of the diagnostic
pathway. Molecular studies are currently under way in
many of our patients and will be available in the near
future for further analysis.
Conclusions
In conclusion, the results of our study emphasize the
importance of prompt ophthalmological evaluation of
infants and children presenting with nystagmus and/or
suspected vision loss. To suspect IRDs, medical history
should specifically focus on the presence of light sensi-
tivity and night blindness. Abnormalities of the visual
fields and color vision should be documented whenever
possible. It is important to recognize that parents might
not readily recognize and report these symptoms. The
timely identification of early clinical clues suggesting
pediatric IRDs, will expedite the diagnostic process and
therefore allowing the affected children to greatly benefit
from early therapies and treatments which can have very
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